论文部分内容阅读
目的探讨药物激发试验在隐匿性Brugada综合征中的应用。方法将高度怀疑为Brugada综合征的9例患者分成两组,分别用缓脉灵(ajmaline)1mg/kg和氟卡尼(flecainide)2mg/kg进行激发试验。以2002年欧洲心脏病协会心律失常组提出的阳性标准为判断标准。结果两组中各有1例患者诱发呈阳性反应。结论药物激发试验有助于隐匿性Brugada综合征的发现。
Objective To investigate the application of drug challenge test in occult Brugada syndrome. Methods Nine patients highly suspected of Brugada syndrome were divided into two groups and challenged with ajmaline 1 mg / kg and flecainide 2 mg / kg, respectively. To 2002 European Heart Association arrhythmia group proposed positive criteria for the judgment. Results One patient in each group had a positive response. Conclusions The drug challenge test is helpful for the discovery of occult Brugada syndrome.